Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Lilly PACKAGE LABEL - Zepbound Multi-Dose Vial - 12.5 mg/0.6 mL Dose (50 mg/2.4 mL [20.8 mg/mL]) Rx Only NDC 0002-6523-11 Zepbound (tirzepatide) injection 50 mg/2.4 mL (20.8 mg/mL) ATTENTION: Contains 4 doses of 12.5 mg/0.6 mL 2.4 mL MULTI-DOSE VIAL For Subcutaneous Use Needles and Syringes are not included Dispense enclosed Medication Guide to each patient
5.2 Metabolic syndrome: Possible role Metabolic syndrome is a severe condition that combines central obesity, high blood pressure, dyslipidemia, and insulin resistance, which collectively increase the risk of heart disease and T2D
Structural repair
Indian Pediatr
43,44 Interpatient variability in absorption, distribution, metabolism, and excretion affects drug bioavailability and exposure
US$ 22.01
US$ 27.61
US$ 27.99
